Epigenetics 2022 speakers announced
Recent Posts
Spotlight on: Melanie Eckersley-Maslin 25 November 2022
Spotlight on: Jessamy Tiffen 25 July 2022
ECR Spotlight on: Alex Woodworth 16 July 2022
Epigenetics 2022: Four weeks left for poster abstract submissions! 15 July 2022
Emma Whitelaw ECR Publication Award 30 June 2022
Epigenetics 2022 – Meet the speakers 17 June 2022
ECR Spotlight on: Kate Giles 31 May 2022
Spotlight on: Luciano Martelotto 30 May 2022
Epigenetics 2022 speakers announced 20 April 2022
Spotlight on: Hamish King 18 April 2022
ECR Spotlight on: William Schierding 6 April 2022
Spotlight on: Louise Bicknell 14 March 2022
Categories
News (57)
Opportunities (3)
Publications (7)
Spotlight on … (16)
World epi news (2)
Archived news
2022 (12)
2021 (9)
2020 (9)
2019 (1)
2018 (6)
2017 (6)
2016 (6)
2015 (17)
2014 (1)
by AEpiA | Apr 20, 2022 | News
Prof Julia Horsfield
Prof Julia Horsfield completed her PhD at the University of Otago in 1995. In 1996, she took up an HRC Overseas Postdoctoral Fellowship to work at the University of Adelaide. There, Julia first became acquainted with control of the cell cycle in development, and took part in forward genetic screens for cell cycle regulators in Drosophila.
Julia then moved to the University of Auckland in late 1999, where she used a forward genetic screen to identify new leukaemia genes in zebrafish. This resulted in the identification of a cell cycle protein – cohesin. Lucky enough to have the opportunity to start her own lab at the University of Otago in 2007, she has spent the last 15 years trying to understand developmental and cancer roles for the cohesin complex. During this time, she created and directs the Otago Zebrafish Facility, and was director for the Genetics Otago Research Centre from 2017-2021.
Prof Richard Young
Prof Richard Young is a professor at the Whitehead Institute and MIT. He studies gene regulation in health and disease.
Richard has served as an advisor to the World Health Organization, the National Institutes of Health and numerous scientific societies and journals. His honours include membership of the National Academy of Sciences and the National Academy of Medicine, and Scientific American has recognized him as one of the top 50 leaders in science, technology and business. Richard has founded and advised companies in the biotechnology and pharmaceutical industry, and currently serves on the boards of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, Dewpoint Therapeutics and Paratus Sciences.
Put these key dates in your diary!
Sponsorship & exhibition opportunities are available.
Contact Atit Shah
Email atit.s@asnevents.net.au
Epigenetics 2022
#AusEpi22
11-14 September 2022
Confirmed invited speakers announced!
Meet our invited speakers - more to come!
Dr Justin Crocker
Dr Justin Crocker received his PhD in 2010 from Dartmouth College. Following a postdoctoral fellowship at Princeton University and Howard Hughes Medical Institute’s Janelia Research Campus, he became a group leader at EMBL Heidelberg.
“The goal of my research group is to reach a level of understanding that will allow the programming and control of developmental fates, extending existing single-cell synthetic biology techniques to whole organism developmental systems. Our work uses new genome engineering technologies, synthetic biology, high-throughput robotics, and single-molecule imaging techniques in live embryos, creating a cross-cutting approach to developmental systems biology.”